Table 2 Factors associated with the risk of severe laboratory-confirmed COVID-19, Mexico 2020
Bivariate analysis | Multiple analysis | |||||||
|---|---|---|---|---|---|---|---|---|
RR | 95% CI | p | RR | 95% CI | p | |||
Sex | ||||||||
Female | 1.00 | 1.00 | ||||||
Male | 1.18 | 1.10 | 1.25 | < 0.001 | 1.13 | 1.06 | 1.20 | < 0.001 |
Age (years) | ||||||||
15–29 | 1.00 | 1.00 | ||||||
30–44 | 1.04 | 0.96 | 1.13 | 0.354 | 1.02 | 0.94 | 1.11 | 0.585 |
45–59 | 1.37 | 1.25 | 1.49 | < 0.001 | 1.26 | 1.15 | 1.38 | < 0.001 |
≥ 60 | 1.61 | 1.45 | 1.79 | < 0.001 | 1.44 | 1.29 | 1.60 | < 0.001 |
Received antyperitc drugs (any) | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 0.96 | 0.90 | 1.02 | 0.198 | 0.96 | 0.90 | 1.01 | 0.136 |
Elapsed days from symptoms onset to health-care seeking | ||||||||
< 1 | 1.00 | 1.00 | ||||||
1–3 | 0.91 | 0.85 | 0.99 | 0.039 | 0.96 | 0.89 | 1.02 | 0.213 |
4 or above | 1.11 | 1.02 | 1.20 | < 0.001 | 1.06 | 0.99 | 1.13 | 0.102 |
Acute symptoms profile | ||||||||
Fever | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.13 | 1.03 | 1.25 | 0.010 | 1.07 | 0.98 | 1.17 | 0.109 |
Odynophagia | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 0.91 | 0.85 | 0.97 | 0.005 | 0.95 | 0.89 | 1.01 | 0.060 |
Myalgia/arthralgia | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 0.92 | 0.85 | 0.99 | 0.031 | 0.95 | 0.88 | 1.02 | 0.142 |
Thoracic pain | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.20 | 1.13 | 1.28 | < 0.001 | 1.16 | 1.10 | 1.24 | < 0.001 |
Personal history of | ||||||||
Tobacco use (ever) | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.15 | 1.04 | 1.28 | 0.009 | 1.06 | 0.97 | 1.17 | 0.210 |
Obesity (BMI 30 or higher) | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.14 | 1.05 | 1.23 | 0.001 | 1.05 | 0.98 | 1.13 | 0.185 |
Chronic obstructive pulmonary disease | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.49 | 1.26 | 1.77 | < 0.001 | 1.12 | 0.95 | 1.31 | 0.183 |
Bivariate analysis | Multiple analysis | |||||||
RR | 95% CI | p | RR | 95% CI | p | |||
Arterial hypertension | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.32 | 1.22 | 1.42 | < 0.001 | 1.05 | 0.97 | 1.14 | 0.207 |
Cardiovascular disease | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.39 | 1.14 | 1.69 | 0.001 | 1.09 | 0.91 | 1.31 | 0.372 |
Type 2 diabetes mellitus | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.34 | 1.23 | 1.47 | < 0.001 | 1.06 | 0.96 | 1.16 | 0.239 |
Chronic kidney disease | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.65 | 1.29 | 2.10 | < 0.001 | 1.31 | 1.04 | 1.64 | 0.020 |
Immunosuppression | ||||||||
No | 1.00 | 1.00 | ||||||
Yes | 1.33 | 1.08 | 1.64 | 0.008 | 1.14 | 0.94 | 1.37 | 0.180 |